Healthcare provider profile · identity verified

Vanessa B Smith, CNP

Nurse Practitioner · FARMINGTON, ME · NPI 1821586827

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	396	118
Lisinopril	Lisinopril	231	64
Albuterol Sulfate Hfa	Albuterol Sulfate	214	68
Omeprazole	Omeprazole	199	56
Levothyroxine Sodium	Levothyroxine Sodium	195	53
Gabapentin	Gabapentin	158	46
Famotidine	Famotidine	149	45
Amlodipine Besylate	Amlodipine Besylate	146	48
Metoprolol Succinate	Metoprolol Succinate	135	45
Montelukast Sodium	Montelukast Sodium	112	35
Pravastatin Sodium	Pravastatin Sodium	111	41
Trazodone Hcl	Trazodone Hcl	107	26
Ozempic	Semaglutide	106	17
Rosuvastatin Calcium	Rosuvastatin Calcium	98	33
Pregabalin	Pregabalin	97	27
Losartan Potassium	Losartan Potassium	95	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	22
Metoprolol Tartrate	Metoprolol Tartrate	93	28
Metformin Hcl Er	Metformin Hcl	92	30
Prednisone	Prednisone	87	64
Duloxetine Hcl	Duloxetine Hcl	86	28
Eliquis	Apixaban	80	30
Pantoprazole Sodium	Pantoprazole Sodium	79	30
Hydrochlorothiazide	Hydrochlorothiazide	78	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	13
Tramadol Hcl	Tramadol Hcl	77	22
Trulicity	Dulaglutide	77	13
Furosemide	Furosemide	74	29
Jardiance	Empagliflozin	74	19
Zolpidem Tartrate	Zolpidem Tartrate	70	16
Fluticasone Propionate	Fluticasone Propionate	66	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	20
Bupropion Xl	Bupropion Hcl	61	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	29
Azithromycin	Azithromycin	59	49
Sertraline Hcl	Sertraline Hcl	58	18
Atenolol	Atenolol	57	16
Potassium Chloride	Potassium Chloride	57	14
Simvastatin	Simvastatin	54	17
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	53	suppressed
Metformin Hcl	Metformin Hcl	51	16
Nystatin	Nystatin	51	17
Escitalopram Oxalate	Escitalopram Oxalate	48	17
Oxycodone Hcl	Oxycodone Hcl	48	16
Ketoconazole	Ketoconazole	46	25
Buspirone Hcl	Buspirone Hcl	42	13
Januvia	Sitagliptin Phosphate	41	14
Naproxen	Naproxen	40	13
Carvedilol	Carvedilol	38	13
Warfarin Sodium	Warfarin Sodium	38	13
Topiramate	Topiramate	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	13
Propranolol Hcl Er	Propranolol Hcl	35	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	35	16
Triamcinolone Acetonide	Triamcinolone Acetonide	35	15
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Allopurinol	Allopurinol	33	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	11
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Bupropion Hcl	Bupropion Hcl	32	14
Alendronate Sodium	Alendronate Sodium	31	11
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Ondansetron Odt	Ondansetron	30	12
Doxycycline Monohydrate	Doxycycline Monohydrate	29	23
Glipizide Er	Glipizide	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	11
Nitroglycerin	Nitroglycerin	29	12
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Clonazepam	Clonazepam	24	suppressed
Invokana	Canagliflozin	24	suppressed
Lorazepam	Lorazepam	24	13
Mupirocin	Mupirocin	24	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Glipizide	Glipizide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Diazepam	Diazepam	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Baclofen	Baclofen	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lactulose	Lactulose	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Epinephrine	Epinephrine	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Linzess	Linaclotide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Rexulti	Brexpiprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error